PD50-03 PATTERN OF EXPRESSION AND MUTATION STATUS OF FGFR2/3 AND NECTIN-4 IN UROTHELIAL CARCINOMA

INTRODUCTION AND OBJECTIVE:The FDA has approved the first targeted therapy for bladder cancer with its accelerated approval of erdafitinib for the treatment of adult patients with locally advanced ...